Effects of Antioxidant and Nitric Oxide on Chemokine Production in TNF-α-stimulated Human Dermal Microvascular Endothelial Cells

Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are reported to be involved in intracellular activation of chemokine expression in vascular endothelial cells by various stimuli. Nevertheless, redox...

Full description

Saved in:
Bibliographic Details
Published inFree radical research Vol. 38; no. 5; pp. 473 - 480
Main Authors Jiang, Mi-Zu, Tsukahara, Hirokazu, Ohshima, Yusei, Sato, Shuko, Todoroki, Yukiko, Hiraoka, Masahiro, Mayumi, Mitsufumi
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 01.05.2004
Subjects
Online AccessGet full text
ISSN1071-5762
1029-2470
DOI10.1080/1071576042000209826

Cover

Abstract Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are reported to be involved in intracellular activation of chemokine expression in vascular endothelial cells by various stimuli. Nevertheless, redox-regulated mechanisms of chemokine expression in human dermal microvascular endothelial cells (HDMEC) remain unclear. This study examined the effects of pyrrolidine dithiocarbamate (PDTC, 0.1 mM) and spermine NONOate (Sper-NO, 1 mM) on the secretion and gene expression of chemokines, interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, regulated upon activation normal T cell expressed and secreted (RANTES), and eotaxin. This study also addresses PDTC and Sper-NO effects on activation of nuclear factor kappa B (NF-κB) induced by TNF-α (10 ng/ml). Treatment with TNF-α for 8 h significantly increased secretion of IL-8, MCP-1, and RANTES, but not of eotaxin, in cultured HDMEC. Up-regulation of these chemokines was suppressed significantly by pretreatment with PDTC or Sper-NO for 1 h, but not by 1 mM 8-bromo-cyclic GMP. The mRNA accumulation of IL-8, MCP-1, RANTES, and eotaxin, and activation of NF-κB were induced by TNF-α for 2 h; all were suppressed significantly by the above two pretreatments. These findings indicate that both secretion and mRNA accumulation of IL-8, MCP-1, and RANTES in HDMEC induced by TNF-α are inhibited significantly by pretreatment with PDTC or Sper-NO, possibly via blocking redox-regulated NF-κB activation. These results suggest that restoration of the redox balance using antioxidant agents or nitric oxide pathway modulators may offer new opportunities for therapeutic interventions in inflammatory skin diseases.
AbstractList Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are reported to be involved in intracellular activation of chemokine expression in vascular endothelial cells by various stimuli. Nevertheless, redox-regulated mechanisms of chemokine expression in human dermal microvascular endothelial cells (HDMEC) remain unclear. This study examined the effects of pyrrolidine dithiocarbamate (PDTC, 0.1 mM) and spermine NONOate (Sper-NO, 1 mM) on the secretion and gene expression of chemokines, interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, regulated upon activation normal T cell expressed and secreted (RANTES), and eotaxin. This study also addresses PDTC and Sper-NO effects on activation of nuclear factor kappa B (NF-kappaB) induced by TNF-alpha (10 ng/ml). Treatment with TNF-alpha for 8 h significantly increased secretion of IL-8, MCP-1, and RANTES, but not of eotaxin, in cultured HDMEC. Up-regulation of these chemokines was suppressed significantly by pretreatment with PDTC or Sper-NO for 1 h, but not by 1 mM 8-bromo-cyclic GMP. The mRNA accumulation of IL-8, MCP-1, RANTES, and eotaxin, and activation of NF-kappaB were induced by TNF-alpha for 2 h; all were suppressed significantly by the above two pretreatments. These findings indicate that both secretion and mRNA accumulation of IL-8, MCP-1, and RANTES in HDMEC induced by TNF-alpha are inhibited significantly by pretreatment with PDTC or Sper-NO, possibly via blocking redox-regulated NF-kappaB activation. These results suggest that restoration of the redox balance using antioxidant agents or nitric oxide pathway modulators may offer new opportunities for therapeutic interventions in inflammatory skin diseases.Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are reported to be involved in intracellular activation of chemokine expression in vascular endothelial cells by various stimuli. Nevertheless, redox-regulated mechanisms of chemokine expression in human dermal microvascular endothelial cells (HDMEC) remain unclear. This study examined the effects of pyrrolidine dithiocarbamate (PDTC, 0.1 mM) and spermine NONOate (Sper-NO, 1 mM) on the secretion and gene expression of chemokines, interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, regulated upon activation normal T cell expressed and secreted (RANTES), and eotaxin. This study also addresses PDTC and Sper-NO effects on activation of nuclear factor kappa B (NF-kappaB) induced by TNF-alpha (10 ng/ml). Treatment with TNF-alpha for 8 h significantly increased secretion of IL-8, MCP-1, and RANTES, but not of eotaxin, in cultured HDMEC. Up-regulation of these chemokines was suppressed significantly by pretreatment with PDTC or Sper-NO for 1 h, but not by 1 mM 8-bromo-cyclic GMP. The mRNA accumulation of IL-8, MCP-1, RANTES, and eotaxin, and activation of NF-kappaB were induced by TNF-alpha for 2 h; all were suppressed significantly by the above two pretreatments. These findings indicate that both secretion and mRNA accumulation of IL-8, MCP-1, and RANTES in HDMEC induced by TNF-alpha are inhibited significantly by pretreatment with PDTC or Sper-NO, possibly via blocking redox-regulated NF-kappaB activation. These results suggest that restoration of the redox balance using antioxidant agents or nitric oxide pathway modulators may offer new opportunities for therapeutic interventions in inflammatory skin diseases.
Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are reported to be involved in intracellular activation of chemokine expression in vascular endothelial cells by various stimuli. Nevertheless, redox-regulated mechanisms of chemokine expression in human dermal microvascular endothelial cells (HDMEC) remain unclear. This study examined the effects of pyrrolidine dithiocarbamate (PDTC, 0.1 mM) and spermine NONOate (Sper-NO, 1 mM) on the secretion and gene expression of chemokines, interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, regulated upon activation normal T cell expressed and secreted (RANTES), and eotaxin. This study also addresses PDTC and Sper-NO effects on activation of nuclear factor kappa B (NF-κB) induced by TNF-α (10 ng/ml). Treatment with TNF-α for 8 h significantly increased secretion of IL-8, MCP-1, and RANTES, but not of eotaxin, in cultured HDMEC. Up-regulation of these chemokines was suppressed significantly by pretreatment with PDTC or Sper-NO for 1 h, but not by 1 mM 8-bromo-cyclic GMP. The mRNA accumulation of IL-8, MCP-1, RANTES, and eotaxin, and activation of NF-κB were induced by TNF-α for 2 h; all were suppressed significantly by the above two pretreatments. These findings indicate that both secretion and mRNA accumulation of IL-8, MCP-1, and RANTES in HDMEC induced by TNF-α are inhibited significantly by pretreatment with PDTC or Sper-NO, possibly via blocking redox-regulated NF-κB activation. These results suggest that restoration of the redox balance using antioxidant agents or nitric oxide pathway modulators may offer new opportunities for therapeutic interventions in inflammatory skin diseases.
Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are reported to be involved in intracellular activation of chemokine expression in vascular endothelial cells by various stimuli. Nevertheless, redox-regulated mechanisms of chemokine expression in human dermal microvascular endothelial cells (HDMEC) remain unclear. This study examined the effects of pyrrolidine dithiocarbamate (PDTC, 0.1 mM) and spermine NONOate (Sper-NO, 1 mM) on the secretion and gene expression of chemokines, interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, regulated upon activation normal T cell expressed and secreted (RANTES), and eotaxin. This study also addresses PDTC and Sper-NO effects on activation of nuclear factor kappa B (NF-kappaB) induced by TNF-alpha (10 ng/ml). Treatment with TNF-alpha for 8 h significantly increased secretion of IL-8, MCP-1, and RANTES, but not of eotaxin, in cultured HDMEC. Up-regulation of these chemokines was suppressed significantly by pretreatment with PDTC or Sper-NO for 1 h, but not by 1 mM 8-bromo-cyclic GMP. The mRNA accumulation of IL-8, MCP-1, RANTES, and eotaxin, and activation of NF-kappaB were induced by TNF-alpha for 2 h; all were suppressed significantly by the above two pretreatments. These findings indicate that both secretion and mRNA accumulation of IL-8, MCP-1, and RANTES in HDMEC induced by TNF-alpha are inhibited significantly by pretreatment with PDTC or Sper-NO, possibly via blocking redox-regulated NF-kappaB activation. These results suggest that restoration of the redox balance using antioxidant agents or nitric oxide pathway modulators may offer new opportunities for therapeutic interventions in inflammatory skin diseases.
Author Tsukahara, Hirokazu
Mayumi, Mitsufumi
Hiraoka, Masahiro
Ohshima, Yusei
Sato, Shuko
Jiang, Mi-Zu
Todoroki, Yukiko
Author_xml – sequence: 1
  givenname: Mi-Zu
  surname: Jiang
  fullname: Jiang, Mi-Zu
  email: htsuka@fmsrsa.fukui-med.ac.jp
– sequence: 2
  givenname: Hirokazu
  surname: Tsukahara
  fullname: Tsukahara, Hirokazu
– sequence: 3
  givenname: Yusei
  surname: Ohshima
  fullname: Ohshima, Yusei
– sequence: 4
  givenname: Shuko
  surname: Sato
  fullname: Sato, Shuko
– sequence: 5
  givenname: Yukiko
  surname: Todoroki
  fullname: Todoroki, Yukiko
– sequence: 6
  givenname: Masahiro
  surname: Hiraoka
  fullname: Hiraoka, Masahiro
– sequence: 7
  givenname: Mitsufumi
  surname: Mayumi
  fullname: Mayumi, Mitsufumi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15293554$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1u1TAQhS1URH_gCZCQV-wC_kmcZINU3d62SKXtoqwtxx6rBscutgPtso_UF-GZ8NUtLFDVla2Z7xzNnNlHOyEGQOgtJR8oGchHSnra9YK0jBDCyDgw8QLtUcLGhrU92dn8e9pUhO2i_Zy_EUJ52_Wv0C7t2Mi7rt1D92trQZeMo8WHobh464wKBatg8LkryWl8UUuAY8Cra5jjdxcAX6ZoFl3pgF3AV-fHze-HJhc3L14VMPh0mVXAR5Bm5fEXp1P8qbKuzYTXwcRyDd7Vzgq8z6_RS6t8hjeP7wH6ery-Wp02Zxcnn1eHZ43mAy3NoEBA3dcOfAKhdTsx0wsxsmnqBmhBiZ5SU8uUj6Ylk6ZWUDFO1miYWsX5AXq_9b1J8ccCucjZZV0nUAHikqUQfcfJQCv47hFcphmMvEluVulO_g2tAuMWqHvlnMBK7YrapFGScl5SIjcHkk8cqGr5f9p_9s-qPm1VLthYQ_0VkzeyqDsfk00qaJclf87gDwPnpys
CitedBy_id crossref_primary_10_1016_j_carrev_2009_12_001
crossref_primary_10_1016_j_atherosclerosis_2010_05_029
crossref_primary_10_1016_j_cardiores_2006_12_018
crossref_primary_10_1007_s12272_009_1122_4
Cites_doi 10.1001/archderm.138.8.1027
10.1146/annurev.immunol.14.1.649
10.1016/S0891-5849(98)00094-X
10.1016/S0002-9440(10)64416-1
10.1016/S0923-1811(00)00138-9
10.1161/01.ATV.14.10.1665
10.1038/sj.bjp.0704463
10.1016/S0891-5849(00)00218-5
10.1007/s004030000134
10.1016/S0891-5849(00)00482-2
10.1128/IAI.69.3.1265-1272.2001
10.1053/gast.2000.8538
10.1006/cyto.2002.0888
10.1016/S0891-5849(00)00251-3
10.1002/jlb.63.6.732
10.1016/S1367-5931(00)00113-7
10.1016/S0955-2863(01)00186-3
10.1007/s00403-001-0276-9
10.1074/jbc.M109358200
10.1182/blood.V88.9.3482.bloodjournal8893482
10.1016/S0165-2478(02)00208-0
10.1073/pnas.93.17.9114
10.1042/bj3470265
10.1006/bbrc.2000.3170
10.1111/j.1365-2133.1997.tb08740.x
10.1006/clim.1999.4829
10.1515/BC.1999.109
10.1016/S0006-2952(99)00296-8
10.1161/01.RES.76.6.980
10.1111/1523-1747.ep12289711
ContentType Journal Article
Copyright 2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004
Copyright_xml – notice: 2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1080/1071576042000209826
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1029-2470
EndPage 480
ExternalDocumentID 15293554
10_1080_1071576042000209826
11228567
Genre Research Article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
00X
03L
0BK
0R~
29H
30N
36B
4.4
53G
5GY
5VS
A8Z
AAGME
AAJMT
AALDU
AALIY
AAMIU
AAPUL
AAPXX
AAQRR
ABCCY
ABDBF
ABFIM
ABJNI
ABJYH
ABLIJ
ABLKL
ABPAQ
ABXUL
ABXYU
ACDHJ
ACGEJ
ACGFS
ACTIO
ACUHS
ADCVX
ADGTB
ADOPC
ADRBQ
ADXPE
ADYSH
AEISY
AENEX
AEOZL
AEPSL
AEYOC
AFKVX
AFOSN
AFRVT
AGDLA
AHDZW
AIJEM
AIYEW
AJWEG
AKBVH
AKOOK
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AMPGV
AQRUH
AURDB
AWYRJ
BABNJ
BFWEY
BLEHA
CAG
CCCUG
COF
CS3
CWRZV
DGEBU
DKSSO
DU5
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
EST
ESX
F5P
H13
HZ~
JEPSP
KRBQP
KSSTO
KWAYT
KYCEM
M44
M4Z
MM.
O9-
P2P
PCLFJ
RNANH
ROSJB
RTWRZ
SV3
TBQAZ
TDBHL
TFDNU
TFL
TFT
TFW
TQWBC
TTHFI
TUROJ
TUS
V1S
ZGOLN
ZXP
~1N
.HR
AAGDL
AAHIA
AAOAP
AAYXX
ABFMO
ABTAA
ACBBU
ACQMU
ADGTR
AFDYB
AFFNX
APNXG
CITATION
HGUVV
LJTGL
NUSFT
OWHGL
RNS
Z0Y
CGR
CUY
CVF
ECM
EIF
NPM
7X8
TASJS
ID FETCH-LOGICAL-c381t-8ae6e157f83be6cc4b2d76692bb58e4ea6711dc4b139d40bc1f6169bfdceb4a33
ISSN 1071-5762
IngestDate Thu Sep 04 22:25:21 EDT 2025
Wed Feb 19 01:54:41 EST 2025
Tue Jul 01 02:15:26 EDT 2025
Thu Apr 24 23:03:08 EDT 2025
Tue May 20 10:47:38 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c381t-8ae6e157f83be6cc4b2d76692bb58e4ea6711dc4b139d40bc1f6169bfdceb4a33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 15293554
PQID 66753081
PQPubID 23479
PageCount 8
ParticipantIDs crossref_citationtrail_10_1080_1071576042000209826
crossref_primary_10_1080_1071576042000209826
pubmed_primary_15293554
informaworld_taylorfrancis_310_1080_1071576042000209826
proquest_miscellaneous_66753081
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2004-05-01
PublicationDateYYYYMMDD 2004-05-01
PublicationDate_xml – month: 05
  year: 2004
  text: 2004-05-01
  day: 01
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Free radical research
PublicationTitleAlternate Free Radic Res
PublicationYear 2004
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References Spiecker M. (CIT0018) 1998; 63
Huber M.A. (CIT0009) 2002; 277
Andoh A. (CIT0013) 2000; 119
Cho N.H. (CIT0006) 2001; 69
Janssen-Heininger Y.M.W. (CIT0025) 2000; 28
Baldwin A.S.J (CIT0010) 1996; 14
Nemeth Z.H. (CIT0015) 2003; 85
Sebastiani S. (CIT0004) 2002
Bowie A (CIT0024) 2000
Goebeler M. (CIT0008) 1997; 108
Wetzler C. (CIT0020) 2000; 274
Khan B.V. (CIT0030) 1996; 93
Spandau U. (CIT0005) 2002; 138
Cooper P.J. (CIT0007) 2000; 95
Ignarro L.J. (CIT0032) 1981; 218
Rowe A. (CIT0031) 1997; 136
Cuzzocrea S. (CIT0012) 2002; 135
Schroder J.M. (CIT0022) 1999; 380
Fitzhugh A.L. (CIT0034) 2000; 28
Munoz C. (CIT0011) 1996; 88
Uchi H. (CIT0023) 2000; 24
Frank S. (CIT0003) 2000; 347
Cascieri M.A. (CIT0001) 2000; 4
Mathews W.R. (CIT0033) 1993; 267
Grandjean-Laquerriere A. (CIT0016) 2002; 18
Grisham M.B. (CIT0017) 1998; 25
Anderegg U. (CIT0002) 2000; 292
Lee Y.W. (CIT0014) 2001; 12
Kim C.H. (CIT0029) 2003; 384
Giustizieri ML. (CIT0019) 2002
Weber C. (CIT0028) 1994; 14
Rahman A. (CIT0027) 1998; 19
Zeiher AM. (CIT0021) 1995
Fuchs J. (CIT0026) 2001; 30
References_xml – volume: 138
  start-page: 1027
  year: 2002
  ident: CIT0005
  publication-title: Arch. Dermatol
  doi: 10.1001/archderm.138.8.1027
– volume: 218
  start-page: 739
  year: 1981
  ident: CIT0032
  publication-title: J. Pharmacol. Exp. Ther
– volume: 14
  start-page: 649
  year: 1996
  ident: CIT0010
  publication-title: Annu. Rev. Immunol
  doi: 10.1146/annurev.immunol.14.1.649
– volume: 25
  start-page: 404
  year: 1998
  ident: CIT0017
  publication-title: Free Radic. Biol. Med
  doi: 10.1016/S0891-5849(98)00094-X
– start-page: 1409
  year: 2002
  ident: CIT0019
  publication-title: Am. J. Pathol
  doi: 10.1016/S0002-9440(10)64416-1
– volume: 24
  start-page: S29—S38
  year: 2000
  ident: CIT0023
  publication-title: J. Dermatol. Sci
  doi: 10.1016/S0923-1811(00)00138-9
– volume: 14
  start-page: 1665
  year: 1994
  ident: CIT0028
  publication-title: Arterioscler. Thromb
  doi: 10.1161/01.ATV.14.10.1665
– volume: 135
  start-page: 496
  year: 2002
  ident: CIT0012
  publication-title: Br. J. Pharmacol
  doi: 10.1038/sj.bjp.0704463
– volume: 267
  start-page: 1529
  year: 1993
  ident: CIT0033
  publication-title: J. Pharmacol. Exp. Ther
– volume: 28
  start-page: 1317
  year: 2000
  ident: CIT0025
  publication-title: Free Radic. Biol. Med
  doi: 10.1016/S0891-5849(00)00218-5
– volume: 292
  start-page: 341
  year: 2000
  ident: CIT0002
  publication-title: Arch. Dermatol. Res
  doi: 10.1007/s004030000134
– volume: 19
  start-page: L533—L544
  year: 1998
  ident: CIT0027
  publication-title: Physiol
– volume: 30
  start-page: 337
  year: 2001
  ident: CIT0026
  publication-title: Free Radic. Biol. Med
  doi: 10.1016/S0891-5849(00)00482-2
– volume: 69
  start-page: 1265
  year: 2001
  ident: CIT0006
  publication-title: Infect. Immun
  doi: 10.1128/IAI.69.3.1265-1272.2001
– volume: 119
  start-page: 211
  year: 2000
  ident: CIT0013
  publication-title: Gastroenterology
  doi: 10.1053/gast.2000.8538
– volume: 18
  start-page: 168
  year: 2002
  ident: CIT0016
  publication-title: Cytokine
  doi: 10.1006/cyto.2002.0888
– volume: 28
  start-page: 1463
  year: 2000
  ident: CIT0034
  publication-title: Free Radic. Biol. Med
  doi: 10.1016/S0891-5849(00)00251-3
– volume: 63
  start-page: 732
  year: 1998
  ident: CIT0018
  publication-title: J. Leukoc. Biol
  doi: 10.1002/jlb.63.6.732
– volume: 4
  start-page: 420
  year: 2000
  ident: CIT0001
  publication-title: Curr. Opin. Chem. Biol
  doi: 10.1016/S1367-5931(00)00113-7
– volume: 12
  start-page: 648
  year: 2001
  ident: CIT0014
  publication-title: J. Nutr. Biochem
  doi: 10.1016/S0955-2863(01)00186-3
– start-page: 552
  year: 2002
  ident: CIT0004
  publication-title: Arch. Dermatol. Res
  doi: 10.1007/s00403-001-0276-9
– volume: 277
  start-page: 1268
  year: 2002
  ident: CIT0009
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.M109358200
– volume: 88
  start-page: 3482
  year: 1996
  ident: CIT0011
  publication-title: Blood
  doi: 10.1182/blood.V88.9.3482.bloodjournal8893482
– volume: 85
  start-page: 41
  year: 2003
  ident: CIT0015
  publication-title: Immunol. Lett
  doi: 10.1016/S0165-2478(02)00208-0
– volume: 384
  start-page: 143
  year: 2003
  ident: CIT0029
  publication-title: Biol. Chem
– volume: 93
  start-page: 9114
  year: 1996
  ident: CIT0030
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.93.17.9114
– volume: 347
  start-page: 265
  year: 2000
  ident: CIT0003
  publication-title: Biochem. J
  doi: 10.1042/bj3470265
– volume: 274
  start-page: 689
  year: 2000
  ident: CIT0020
  publication-title: Biochem. Biophys. Res. Commun
  doi: 10.1006/bbrc.2000.3170
– volume: 136
  start-page: 18
  year: 1997
  ident: CIT0031
  publication-title: Br. J. Dermatol
  doi: 10.1111/j.1365-2133.1997.tb08740.x
– volume: 95
  start-page: 51
  year: 2000
  ident: CIT0007
  publication-title: Clin. Immunol
  doi: 10.1006/clim.1999.4829
– volume: 380
  start-page: 889
  year: 1999
  ident: CIT0022
  publication-title: Biol. Chem
  doi: 10.1515/BC.1999.109
– start-page: 13
  year: 2000
  ident: CIT0024
  publication-title: Biochem. Pharmacol
  doi: 10.1016/S0006-2952(99)00296-8
– start-page: 980
  year: 1995
  ident: CIT0021
  publication-title: Circ. Res
  doi: 10.1161/01.RES.76.6.980
– volume: 108
  start-page: 445
  year: 1997
  ident: CIT0008
  publication-title: J. Invest. Dermatol
  doi: 10.1111/1523-1747.ep12289711
SSID ssj0013457
Score 1.7575701
Snippet Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 473
SubjectTerms Antineoplastic Agents - pharmacology
Antioxidants
Antioxidants - pharmacology
Chemokines
Chemokines - metabolism
Dermis - blood supply
Endothelial activation
Endothelium, Vascular - drug effects
Endothelium, Vascular - metabolism
Humans
Microcirculation - cytology
NF-kappa B - metabolism
Nitric oxide
Nitric Oxide - pharmacology
Nuclear factor kappa B
Oxidation-Reduction
Reactive oxygen species
Tumor Necrosis Factor-alpha - pharmacology
Title Effects of Antioxidant and Nitric Oxide on Chemokine Production in TNF-α-stimulated Human Dermal Microvascular Endothelial Cells
URI https://www.tandfonline.com/doi/abs/10.1080/1071576042000209826
https://www.ncbi.nlm.nih.gov/pubmed/15293554
https://www.proquest.com/docview/66753081
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELagKwEXBAss5ekDt2LIw3kdV0urarXtHmhF2UtkJ44atU1WbSOhPfPDGT-apFCWxyWKnNqNPJ8n4_E3Mwi9owmV5EGbMBGlhAZWRFgibOI6ieMGXhTRSAYKj8b-cErPZ96soQ6p6JIt_5DcHIwr-R-pQhvIVUbJ_oNk60GhAe5BvnAFCcP1r2Tcb8gYTLIWv-UpM5RxWKmSIy-bhDwQANmsyoU0Ka91jlfDcZyMB0TF2xJY6ytZywssUF24L5VKe9lbScpeTVgVRSpjtpbS0S6d_pu2dTtYC9FbM330Y9II1e7m89y4pkc5uapqj8GmWjCZNFp9A_N1uWA39cPL-Waer9Sjr9VG5LU7iKniT73P82pR7vktaMMSNKoWjBvi_aSL3bCFOa-lWKkuePKLwtcMSTkWDAUKSB2tRqFzIL32-DIeTC8u4kl_NrmLjpwAjK0OOjodfrr60hw8UZUctn65XaKq0Pp44E_2jJm9VLe_37Aow2XyCD00Ow58quHzGN0RxTG6f7Yr9HeM7o0Mv-IJ-m4QhcsMtxAF9ynWiMIKUbgscI0o3CAK5wU-hCisEIU1ovAeonALUVgh6imaDvqTsyExdTpIAvbeloRM-AKmJgtdLvwkodxJYXIjh3MvFFQwP7DtFJpht5FSiyd25tt-xLM0EZwy132GOkVZiOcIczB4oSXwGHwnbJFFlstCMKKFZ3GfhayLnN2Ex4lJYi9rqSxj2-S6PSClLnpfd7rWOVxu_3nQlmS8Va6zTNe5id1be77dCT0GGco5Y4Uoq03sw77cBeu7i040FpoX8RxZ4oC--GPfl-hBs45eoc52XYnXYBFv-RuD4h86nrbe
linkProvider Library Specific Holdings
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwELWgSLQXPgoty1d94IirOHac-FgtXS3QDRy2Um-R7TjSqiFBbFZC3PhJ_BF-EzNxQltUeoBTJCtjx_HYfsk8vyHklXQSyYOcGa9LJtNIM-M8ZyJ2sUgTraXGg8KLXM1P5buz5OzSKX6kVeI3dBWEIvq1Gic3_oweKXFwTTngZPC3PpKmASLfJncSAONI6hNRfhFHkL3WJxowsIhH3aHrK7myN11RLv07_uz3odl9YsYeBPrJ-eGms4fu2x_ijv_TxQfk3gBS6VHwqofklm92yfZ0zA23S-4uhpD8I_I96B-vaVvRI6ROfl2VMFoUmqb5CvX_6Qco8rRtKNbQnoMZ_RiEZsEp6Kqhy3zGfv5gsNp8wmxivqR9bIG-wW2jpgskDY6UWXrclHhqrIaJQ6e-rtePyenseDmdsyGvA3OADzqWGa889K7KhPXKOWnjMlVKx9YmmZfeqJTzEooBnZYyso5Xiittq9J5K40Qe2SraRv_hFALAAlK0sTAusJ9pSNhMgBdPomsMpmZkHgc0cINoueYe6Mu-KCNes2LnpDXv40-B82Pm29PL7tK0fW_WqqQF6UQN1oejF5VwABiqMY0vt2sCwXfcQLQ2oTsB2e7eJAkRkl8-fSfWz0g2_Pl4qQ4eZu_f0Z2AhUJGZzPyVb3ZeNfAMrq7Mt-Iv0CoOIYew
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB1BkQoXCoXC8lUfOOIqjh0nPlbbrsrHhh5aqbdgO460akgqNiuh3vqT-CP8JsZx0lJUeoBTJCvjxPHYfs48vwF4K6zw5EFGtVMlFWmkqLaOUR7bmKeJUkL5g8LzXB4ciw8nycmQ53Q50Cr9HroKQhH9XO0H91lZjYw4vKYMYTK6Wx9IU4iQ78I9GXHlxfN5lF-FEUQv9ekNKFrEo-zQzZVcW5quCZf-HX72y9BsA76MDQjsk9OdVWd27Pkf2o7_0cJH8HCAqGQ3-NRjuOOaTbg_HTPDbcL6fAjIP4GLoH68JG1Fdj1x8vuixL4i-GSSL7z6P_mMRY60DfE1tKdoRg6DzCy6BFk05Cif0Z8_KM41X30uMVeSPrJA9vyiUZO5pwyOhFmy35T-zFiNw4ZMXV0vn8LxbP9oekCHrA7UIjroaKaddNi6KuPGSWuFictUShUbk2ROOC1TxkosRmxaishYVkkmlalK64zQnG_BWtM27jkQg_AIS9JE46zCXKUirjOEXC6JjNSZnkA8dmhhB8lzn3mjLtigjHrDh57Au0ujs6D4cfvt6e-eUnT9j5YqZEUp-K2W26NTFdiBPlCjG9euloXEXRxHrDaBZ8HXrl4kib0gvnjxz0_dhvXDvVnx6X3-8SU8CDwkT998BWvdt5V7jRCrM2_6YfQLLRYXKA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+antioxidant+and+nitric+oxide+on+chemokine+production+in+TNF-alpha-stimulated+human+dermal+microvascular+endothelial+cells&rft.jtitle=Free+radical+research&rft.au=Jiang%2C+Mi-Zu&rft.au=Tsukahara%2C+Hirokazu&rft.au=Ohshima%2C+Yusei&rft.au=Sato%2C+Shuko&rft.date=2004-05-01&rft.issn=1071-5762&rft.volume=38&rft.issue=5&rft.spage=473&rft_id=info:doi/10.1080%2F1071576042000209826&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1071-5762&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1071-5762&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1071-5762&client=summon